Megaesophagus Associated with Gastro-Oesophageal Junction Neoplasia in Dogs: 7 Cases (2004–2016)
27th ECVIM-CA Congress, 2017
V. Fabres1; F. Jolivet2; M. Massal2; O. Dossin2; V. Freiche1
1National School of Alfort, Maisons-Alfort, France; 2ENVT, University of Toulouse, Toulouse, France

Oesophageal neoplasia has been reported in dogs with regurgitations but only anecdotal case-reports describe megaoesophagus associated with gastroesophageal junction (GEJ) neoplasia. This retrospective case series reports 7 cases of megaoesophagus associated with GEJ neoplasia in dogs. Median (range) age and weight at presentation were 12 (10–14) years and 26 (19–29.3) kg, respectively. All cases were medium to large breed dogs. Duration of clinical signs ranged from 3 days to 3 months with clinical signs including regurgitations (7), weight loss (6), cough (4), polydipsia (3), ptyalism (2), lethargy (2), cachexia (2), and increased lung sounds (2). Plain thoracic radiographs showed a megaoesophagus (7), a soft-tissue opacity within the caudal oesophagus (3), and signs of aspiration pneumonia (2). GEJ mass was confirmed by contrast oesophagogram in two dogs. Transabdominal ultrasonography of the GEJ was performed in 6 dogs and was abnormal in 5 dogs. Endoscopy performed in 4 cases revealed a protruding mass in all cases. CT imaging performed in 3 cases showed a mass at the GEJ. One dog was treated by GEJ stenting, resulting in resolution of clinical signs; this dog is still alive. Six dogs were euthanized before diagnosis or lost to follow-up. Biopsies of the oesophageal masses were obtained endoscopically (2), surgically (1) or after necropsy (3) and revealed oesophageal leiomyoma (3) and leiomyosarcoma (1) but the endoscopic samples were non-diagnostic. Considering that long term survival is possible, this case series emphasizes the importance of using additional imaging diagnostic procedures before diagnosing idiopathic megaoesophagus.

Disclosures

Disclosures to report.
The residency program of Dr V. Fabres is partly financed by Royal Canin. Unrelated to the subject matter of the abstract.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

V. Fabres
National School of Alfort
Maisons-Alfort, France


MAIN : ESCG : Gastro-Oesophageal Junction Neoplasia
Powered By VIN
SAID=27